Paladin Labs
Shima Jalali possesses extensive experience in quality assurance and regulatory affairs within the pharmaceutical industry. Currently serving as a Quality Services Specialist at Paladin Labs since May 2021, Shima leads the Annual Product Quality Review report process for Canadian drug products and manages corrective and preventive actions with suppliers. Previous roles include pharmaceutical QA consultant at Amaris Consulting, where Shima conducted medical device validations and nonconformity investigations, and quality assurance associate at Accord Healthcare, focusing on product release and quality management systems. Shima's early career involved quality assurance and control positions at various companies, including Parseh Intelligent Co. and POUYA Nanotechnology Development Co. Educational qualifications include a DEC in Biopharmaceutical Production Technology from CEGEP - John Abbott College and a Bachelor of Applied Science in Cell/Cellular and Molecular Biology-Microbiology from the University of Tehran.
Paladin Labs
Paladin Labs Inc., headquartered in Montreal, Canada, is a specialty pharmaceutical company focused on acquiring or in-licensing innovative pharmaceutical products for the Canadian market. Paladin has a focused marketing and sales organization that has helped it evolve into a well-known Canadian specialty pharmaceutical company with a breadth of products. Paladin is an operating company of Endo International plc (NASDAQ: ENDP), a highly focused generics and specialty branded pharmaceutical company delivering quality medicines to patients through excellence in development, manufacturing and commercialization.